Drug Research
Regulatory Challenges In Radiopharmaceuticals And The CAGT
The life sciences industry is going through a big change right now, thanks to the fast growth of new treatments like cell and gene therapies (CAGT) and big new investments in radiopharmaceuticals. These new ideas have the ability to...
Drug Research
IAEA Unveils New Database For Global Radiopharmaceuticals
Research, cooperation, and the sustainability of safe radiopharmaceuticals for clinical application will be aided by a new IAEA radiopharmacy database. To compile into the new online database, the IAEA is now gathering data on facilities that manufacture medical radioisotopes...
Drug Research
How Are ADCs Improving Cancer Treatments With Precision
ADCs could lead to better and more efficient treatments in the complex and specialized field of tailored cancer medicines. ADCs are made up of a monoclonal antibody that is permanently linked to a lethal drug. They were created as...
Drug Research
Antibody Drug Conjugates: Future Therapies And Treatment
Beyond cancer, there are a number of sectors that provide considerable prospects for antibody drug conjugates (ADCs), using their capacity to deliver therapeutic drugs selectively to sick cells or tissues while avoiding off-target effects. These opportunities may be used...
Drug Research
Advancements In ADCs: Important Trends And Market Insights
Antibody drug conjugates (ADCs) are the main players in the fields of cancer clinical research and deal-making, with new alliances and contracts appearing on a regular basis. Businesses set themselves apart as the ADC market grows increasingly saturated by...
Drug Research
AI In Pharma: Speeding Up Drug Discovery And Innovation
The world is very interested in generative artificial intelligence (GAI), and for good reason. People have a better idea of what AI can do thanks to platforms like ChatGPT that have shown what it can do. AI is also...
Drug Research
FDA Workshop On AI In Drug Development: The Key Takeaways
A full-day training called Artificial Intelligence in Drug and Biological Product Development was held on August 6, 2024, by the Food and Drug Administration (FDA) and the Clinical Trials Transformation Initiative (CTTI). There were four panels at the workshop,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
